Monthly production capacity: 100 g. Current stock: 500g of high-purity venom.
Continuous cold-chain protection and storage below - 42°C to preserve biological activity.
Long-term, licensed and reliable partnerships for pharmaceutical, biotechnology and medical research institutions.
BIO SA Green
Production Process
A laboratory environment that closely replicates the natural habitat to prevent stress and maximize venom quality.
Meticulous venom extraction performed by expert biologists without harming the animal.
The collected high-purity venom is immediately placed under a -42°C cold-chain protocol to preserve biological activity.
Scorpion venom is not merely a defense mechanism; it is an evolutionarily refined collection of active components with significant medical potential.
Short-chain peptides that act on the nervous system and target specific ion channels. A key focus of neurological research.
Protein structures that help cross cellular barriers and catalyze biological eactions.
Active molecules that modulate cellular processes by breaking down proteins.
Proteomik Analysis
A broad amino acid spectrum (20+ variants detected) supports the molecule's structural integrity and biocompatibility. The highest concentrations were measured for Taurine and Arginine.
Official literature and regulatory analysis conducted by Chemreach Engineering and Consultancy.
Androctonus crassicauda is not listed in CITES Appendices I, II or III.
Trade and scientific use can proceed under standard import-export and biosafety regulations without the international CITES permit system.
100% pure A. crassicauda venom, rich in short-chain peptides below 10 kDa, collected under low-stress laboratory conditions.
Sustainable monthly production capacity of 100 g and end-to-end cold-chain logistics at - 42°C to preserve active molecule integrity.
A licensed and transparent biological supply partnership open to global trade without CITES restrictions.
